SZENT-GYÖRGYI JUNIOR MENTORS MÁTÉ MANCZINGER University of Szeged, Department of Dermatology and Allergology Address: Korányi fasor 6., H-6720 Szeged, Hungary E: manczinger.mate@med.u-szeged.hu T: +36 62/545-260 RESEARCH AREA The adaptive immune system has to differentiate between harmful and non-harmful agents. If differentiation is insufficient, either defense against pathogens is inappropriate or recognition of non-harmful peptides leads to allergy and autoimmunity. All of these indicate, that immune recognition is complex, but finely tuned at the same time. In our research, we examine adaptive immune recognition and its role in the pathogenesis of diseases. We are investigating infectious, autoimmune diseases and asthma at present. Additionally, the role of adaptive immunity in antitumor defense is also being examined. We mainly use bioinformatic tools for our analyses. TECHNIQUES AVAILABLE IN THE LAB Programming in “R” language. Big data analysis, Statistical analysis, database processing, immunoinformatic analysis. SELECTED PUBLICATIONS Manczinger, M., Kemény, L. (<strong>2016</strong>) Method and nontransitory computer-readable computer program product for identification of effective drugs. US Patent App 15: 198,366. Manczinger, M., Bocsik, A., Kocsis, G.F., Vörös, A., Hegedűs, Z., Ördögh, L., Kondorosi, É., Marton, A., Vízler, C., Tubak, V., Deli, M., Kemény, L., Nagy, I., Lakatos, L. (2015) The absence of N-Acetyl-D-glucosamine causes attenuation of virulence of Candida albicans upon interaction with vaginal epithelial cells in vitro. Biomed Res Int 2015: 398045. Manczinger, M., Kemény, L. (2013) Novel factors in the pathogenesis of psoriasis and potential drug candidates are found with systems biology approach. PLOS ONE 8: e80751. Manczinger, M., Szabó, E.Z., Göblös, A., Kemény, L., Lakatos, L. (2012) Switching on RNA silencing suppressor activity by restoring argonaute binding to a viral protein. J Virol 86: 8324-7. 86
SZENT-GYÖRGYI JUNIOR MENTORS NIKOLETTA NAGY Department of Medical Genetics, University of Szeged, Address: Somogyi u. 4., H-6720 Szeged, Hungary E: nagy.nikoletta@med.u-szeged.hu nikoletta.nagy@gmail.com T: +36 62/545-134 RESEARCH AREA My main research interest is the identification of genetic susceptibility factors predisposing to the development of rare (monogenic) and common (multifactorial) skin diseases. Currently I am working on a rare skin disease, Brooke-Spiegler syndrome, characterized by the development of significantly stigmatizing tumors of the skin appendages. These studies would give the basis of the development of future genetic and pharmacogenomics screening tests with diagnostic or therapeutic purposes. Another field of interest is the development and Research area of causative treatment strategies such as cell-, gene-therapy methods. TECHNIQUES AVAILABLE IN THE LAB Basic DNA techniques (genomic and cell free DNA isolation, PCR preparation, gel electrophoresis, sequencing, digital PCR measurements), polymorphism studies in multifactorial diseases, mutation screening in rare diseases, gene and protein expression analysis (Q-RT-PCR, Western blot), isolation and culturing of human cells, using skin organotypic model, transfection into human cell lines, RNA silencing, basic cell biology studies (migration, proliferation assays). SELECTED PUBLICATIONS Koumbaris, G., Kypri, E., Tsangaras, K., Achilleos, A., Mina, P., Neofytou, M., Velissariou, V., Christopoulou, G., Kallikas, I., González-Liñán, A., Benusiene, E., Latos-Bielenska, A., Marek, P., Santana, A., Nagy, N., Széll, M., Laudanski, P., Papageorgiou, E.A., Ioannides, M., Patsalis, P.C. (<strong>2016</strong>) Cell- Free DNA Analysis of Targeted Genomic Regions in Maternal Plasma for Non-Invasive Prenatal Testing of Trisomy 21, Trisomy 18, Trisomy 13, and Fetal Sex. Clin Chem 62: 848-55. Rebane, A., Runnel, T., Aab, A., Maslovskaja, J., Ruckert, B., Zimmermann, M., Plaas, M., Kaner, J., Treis, A., Pihlap, M., Haljasorg, U., Hermann, H., Nagy, N., Kemeny, L., Erm, T., Kingo, K., Li, M., Boldin, M.P., Akdis, C.A. (2014) MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes. J Allergy Clin Immun 134: 836- 847. Rebane, A., Zimmermann, M., Aab, A., Baurecht, H., Koreck, A., Karelson, M., Abram, K., Metsalu, T., Pihlap, M., Meyer, N., Folster-Holst, R., Nagy, N., Kemeny, L,, Kingo, K., Vilo, J., Illig, T., Akdis, M., Franke, A., Novak, N., Weidinger, S., Akdis, C.A, (2012) Mechanisms of IFN-gamma-induced apoptosis of human skin keratinocytes in patients with atopic dermatitis, J Allergy Clin Immun 129: 1297-1306. Tanaka, A. Weinel, S., Nagy, N., O’Driscoll, M., Lai-Cheong, J.E., Kulp-Shorten, C.L., Knable, A., Carpenter, G., Fisher, S.A., Hiragun, M., Yanase, Y., Hide, M., Callen, J., McGrath, J.A. (2012) Germline mutation in ATR in autosomal- dominant oropharyngeal cancer syndrome. Am J Hum Genet 90: 511- 5<strong>17</strong>. Nagy, N., Almaani, N., Tanaka, A., Lai-Cheong, J.E., Techanukul, T., Mellerio, J.E., McGrath, J.A. (2011) HB-EGF induces COL7A1 expression in keratinocytes and fibroblasts: possible mechanism underlying allogeneic fibroblast therapy in recessive dystrophic epidermolysis bullosa. J Invest Dermatol 131: <strong>17</strong>71-74. 87